Valuation: Aspen Pharmacare Holdings Limited

Market Cap 70.44B 4.3B 3.77B 3.55B 3.24B 6.06B 412B 6.1B 42.58B 16.51B 210B 16.14B 15.78B 680B P/E 2026
26.3x
P/E 2027 * 14.5x
Enterprise Value 83.32B 5.08B 4.46B 4.19B 3.83B 7.16B 487B 7.22B 50.37B 19.53B 248B 19.09B 18.67B 805B EV / Sales 2026
-
EV / Sales 2027 * 1.84x
Free-Float
58.39%
Yield 2026
1.48%
Yield 2027 * 1.56%
1 day-0.53%
1 week+1.46%
Current month+0.21%
1 month+7.46%
3 months+4.84%
6 months+23.54%
Current year+35.83%
1 week 152.89
Extreme 152.89
166.21
1 month 140
Extreme 140
166.21
Current year 104.38
Extreme 104.38
166.21
1 year 90.7
Extreme 90.7
166.21
3 years 90.7
Extreme 90.7
252.96
5 years 90.7
Extreme 90.7
281.67
10 years 64.07
Extreme 64.07
327.5
Manager TitleAgeSince
Chief Executive Officer 62 1996-12-31
Director of Finance/CFO 61 2008-12-31
Chief Operating Officer 63 1998-12-31
Director TitleAgeSince
Director/Board Member 62 1998-12-31
Director/Board Member 65 1998-12-31
Chairman 58 2015-12-06
Date Insider Type Main position Quantity % Market Cap. Importance
9/27/23 Free

Chief Operating Officer

12,236 0.0027%
9/27/23 Free

Executive/Senior Manager

11,728 0.0026%
9/27/23 Free

Founder

10,558 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%+1.46%+58.80%-8.15% 4.3B
+0.09%-0.04%+14.72%+66.06% 46.71B
-1.93%-2.89%+34.41%+103.01% 36.9B
-0.05%+3.08%+12.94%+93.93% 12.18B
+0.51%+1.13%-9.51%+18.01% 11.66B
+0.19%-0.95%+20.37%+140.74% 8.97B
-0.99%+1.44%+21.41%+211.99% 7.29B
+0.56%+0.56%+26.32%+37.72% 7.21B
+0.57%+0.63%+39.57%-15.49% 7.09B
-0.64%+4.03%-43.43%+10.76% 5.12B
Average -0.19%+1.59%+17.56%+65.86% 14.74B
Weighted average by Cap. -0.41%+0.72%+19.29%+76.18%

Financials

2026 2027 *
Net sales 37.62B 2.29B 2.01B 1.89B 1.73B 3.23B 220B 3.26B 22.74B 8.82B 112B 8.62B 8.43B 363B 37.04B 2.26B 1.98B 1.86B 1.7B 3.18B 216B 3.21B 22.39B 8.68B 110B 8.48B 8.3B 358B
Net income 4.8B 293M 257M 241M 221M 413M 28.04B 416M 2.9B 1.12B 14.29B 1.1B 1.08B 46.35B 4.77B 291M 255M 240M 219M 410M 27.87B 413M 2.88B 1.12B 14.21B 1.09B 1.07B 46.07B
Net Debt 12.88B 786M 689M 648M 593M 1.11B 75.25B 1.12B 7.78B 3.02B 38.37B 2.95B 2.89B 124B -2.41B -147M -129M -121M -111M -208M -14.11B -209M -1.46B -566M -7.19B -553M -541M -23.32B
Logo Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (68.4%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (31.6%): infant nutrition products and consumer products. At the end of June 2024, the group had 24 production sites worldwide.
Employees
9,343
Date Price Change Volume
26-09-23 ZAR 158.64 -0.53% 1,345,652
26-09-22 ZAR 159.48 -2.98% 1,387,307
26-09-21 ZAR 164.38 +5.68% 1,933,897
26-09-18 ZAR 155.54 -0.16% 14,190,051
26-09-17 ZAR 155.79 -0.36% 2,219,789
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
158.64ZAR
Average target price
172.67ZAR
Spread / Average Target
+8.84%

Annual profits - Rate of surprise